Amneal (AMRX) | Stock Overview & Key Data
Amneal Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $24.48 on August 20, 2018
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Amneal AMRX | 3.25B Mid-cap | -1.06% | 4.04% | 23.53% | 38.49% | 32.60% | 20.07% | 425.00% | 99.81% |
| Zoetis ZTS | 65.09B Large-cap | 2.03% | -3.94% | -8.02% | -8.26% | -9.96% | -22.95% | -0.64% | -11.49% |
| Haleon Plc - ADR HLN | 41.85B Large-cap | 1.58% | -7.49% | -10.25% | -6.53% | -4.45% | -10.25% | 49.34% | 21.73% |
| Regencell Bioscience RGC | 9.59B Mid-cap | 14.18% | 35.89% | 5.98% | 2,264.10% | 14,084.62% | 11,425.00% | 2,326.32% | 6,485.71% |
| Alkermes plc ALKS | 5.11B Mid-cap | 0.38% | 12.68% | 4.67% | 8.92% | 9.15% | 8.54% | 38.73% | 83.19% |
| Prestige Consumer PBH | 3.79B Mid-cap | -0.08% | -4.88% | -20.38% | -24.52% | -19.21% | -9.76% | 24.02% | 73.02% |
Ownership & Short Interest
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AMRX's 52-week high and low?
- In the last 52 weeks, Amneal reached a high of $10.68 (on October 3, 2025) and a low of $6.68 (on April 10, 2025).
- What is the market cap and P/E ratio for AMRX?
- Curious about Amneal's size and valuation? Its market capitalization stands at 3.25B. When it comes to valuation, the P/E ratio (trailing twelve months) is 1,036.00, and the forward P/E (looking ahead) is 14.59.
- Does AMRX pay dividends? If so, what's the yield?
- As for dividends, Amneal isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Amneal's main competitors or similar companies to consider before investing?
When looking at Amneal, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Zoetis
ZTS65.09B Healthcare Drug Manufacturers - Specialty & Generic -22.95% -0.64% Haleon Plc - ADR
HLN41.85B Healthcare Drug Manufacturers - Specialty & Generic -10.25% 49.34% Regencell Bioscience
RGC9.59B Healthcare Drug Manufacturers - Specialty & Generic 11,425.00% 2,326.32% Alkermes plc
ALKS5.11B Healthcare Drug Manufacturers - Specialty & Generic 8.54% 38.73% Prestige Consumer
PBH3.79B Healthcare Drug Manufacturers - Specialty & Generic -9.76% 24.02% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Amneal Pharmaceuticals Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Amneal's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 106.73%, the Debt to Equity ratio from the most recent quarter is -22.94, and its Gross Profit Margin stands at 39.51%.
- What is the recent revenue and earnings growth for AMRX?
- Looking at Amneal's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.20%, and quarterly earnings saw a YoY growth of 274.00%.
- How much of AMRX stock is held by insiders and institutions?
- Wondering who owns Amneal stock? Company insiders (like executives and directors) hold about 46.49% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 45.92%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.